Intra-and post-operative analgesic effects of pre-operative administration of carprofen were investigated in 16 medetomidine
INTRODUCTION
For a long time opioids have been used as a single analgesic drug in veterinary practice. In recent years, there have been significant advances in the control of pain in animals (Lascelles 1996) . Multimodal or balanced analgesic regimens that involve the use of combination of two or more analgesic drugs have been implemented to provide either an additive or synergistic analgesic effect of different drugs used (Dahl and Kehlet 1993 ). This approach is thought to be more likely to provide optimum analgesia than the use of a single analgesic agent (Kehlet 1994 ). Combinations of opioids and non-steroidal anti-inflammatory drugs (NSAID) are currently used in veterinary practice.
It has been realized as well, that the timing of analgesic intervention may have a significant bearing on postoperative pain. The changes in central processing of noxious signals occurring in response to peripheral injury could be markedly decreased or prevented by preinjury treatment with opioids or NSAIDs. These treatments have been far less effective if administered after the injury was initiated , Coderre et al., 1993 . The use of analgesics before the noxious stimulus may markedly reduce the severity of postoperative pain, and pre-emptive analgesia has been quickly transposed to the clinical practice.
Carprofen, the NSAID licensed for peri-and post-operative use in dogs is a propionic acid derivative (6-chloro-alpha-methyl-carbazole-2-acetic-acid) that, at therapeutic doses, seems to be a poor inhibitor of prostaglandin synthetase i.e. cyclooxygenase, the enzyme responsible for the synthesis of inflammatory mediators produced by tissue damage . Despite the apparent lack of cyclooxygenase inhibition, studies have shown it to be a good analgesic in both acute and chronic pain states, and to be a very effective analgesic in dogs undergoing surgical procedures Reid 1993, Lascelles et al., 1994) .
Medetomidine is a potent and highly specific a 2 -adrenergic agonist that provides reliable sedation, analgesia, muscle relaxation, and anxiolysis, as well as a decrease in the anaesthetic requirements of injectable and inhalant agents. It is frequently used as a premedication drug before general anaesthesia in dogs and cats . Lower doses of medetomidine ranging from 2 to 10 mg/kg have been combined with various opioids such as butorphanol, oxymorphone, hydromorphone, buprenorphine and meperidine to enhance sedation and analgesia, while potentially reducing the duration and severity of the adverse cardiovascular effects associated with medetomidine use in higher doses Verstegen 1998, Sinclair 2003) .
To our knowledge, there have been no published studies demonstrating the efficacy of pre-operative administration of carprofen to medetomidinepremedicated dogs in the control of intra-and post-operative pain. The aim of the present study was to investigate intra-and post-operative analgesic effects of carprofen in medetomidine-premedicated dogs undergoing ovariectomy. 
Animals
Sixteen healthy bitches admitted for elective ovariectomy to the Clinic for Small Animal Medicine and Surgery, Veterinary Faculty in Ljubljana, Slovenia were entered into the study. A variety of breeds between 6.5 months and 8 years of age were represented; the dogs weighed between 9.5 and 40.5 kg. After admission to the hospital, all dogs were housed in the same surgical ward and were allowed a minimum of one hour for acclimatisation to the hospital surroundings before other activities were initiated. To be included in the study, the dogs were required to have a physical examination and pre-operative blood analysis i.e. complete blood count and serum biochemistry profile including blood urea nitrogen, creatinine, potassium, sodium and chloride. No administration of medications one month before the trial was permitted. The dogs were withheld food for 12 hours and were allowed to have access to water up until two hours before induction of anaesthesia.
Study design
Eight of the dogs were given carprofen (Rimadyl, Pfizer) 4 mg/kg intramuscularly and eight were given placebo (Aqua redestillata, Pliva) 0.08 ml/kg intramuscularly into the left caudal thigh muscles. The volume of placebo was equal to the volume of carprofen used. The trial was conducted under double blind conditions. The choice of drug given to each dog was determined by the allocation of a random number. The drugs were administered by one of the investigators and the other two, who did not know which drug the dog had received, carried out all the assessments throughout the procedure.
Dogs were premedicated with medetomidine (Domitor, Orion) 1000 mg/m 2 of body surface intramuscularly into the right caudal thigh muscles, given about 20 minutes after carprofen or placebo administration. They were left undisturbed 20 minutes after medetomidine administration, after which the pulse rate (a. femoralis), respiratory rate and rectal body temperature were measured. A catheter was introduced into the cephalic vein and anaesthesia was induced with propofol (Diprivan, Zeneca Pharmaceuticals Ltd) 1 mg/kg intravenously. The dogs were endotracheally intubated and connected to an anaesthesia machine (Dräger Tiberius 800) using a circle circuit. Anaesthesia was maintained using isoflurane (Isofluran, Torrex Pharma GmbH) at end-tidal isoflurane concentration (F E 'ISO) 1.0 % delivered in 100% oxygen at a flow 20 ml/kg/min. The dogs were allowed to breathe spontaneously throughout the procedure. Atipamezole (Antisedan, Orion) 2500 mg/m 2 of body surface was administered intramuscularly 15 minutes after the end of the surgery to antagonise the effects of medetomidine.
A catheter was introduced percutaneously into a femoral artery for the purpose of monitoring arterial blood pressure. A urinary catheter was introduced and the bladder evacuated. The dogs were positioned in a dorsal recumbency on a heated surgical The following parameters were recorded during anaesthesia: heart rate (HR), mean arterial blood pressure (MAP), oesophageal body temperature (T) and ECG (Hewlett Packard 78354A), respiratory rate (RR), end-tidal CO 2 (ETCO 2 ), F E 'ISO and arterial oxygen saturation measured by pulse oximetry (SpO 2 ; Ohmeda 5250 RGM), tidal volume of respiration (TV; mechanical volumetry, Dräger Tiberius 800). Measurements were taken at the following phases of surgery: baseline (1), skin incision (2), incision of abdominal wall (3), traction of left ovarian ligament (4), no surgical stimulation (5), traction of right ovarian ligament (6) , suturing the abdominal wall (7), suturing the skin (8), end of the surgery (9), 15 minutes after the end of the surgery (10).
Assessments of sedation and analgesia
During general anaesthesia, the dogs were monitored for signs of nociception including the changes in HR, MAP, RR and TV as a response to the painful surgical stimulation. Subanaesthetic dose of ketamine (Ketanest, ParkeDavis, 0.5 mg/kg intravenously) was given, when additional analgesia was thought to be necessary (20% or more increase in HR, RR or MAP, or presence of spontaneous movements).
Assessments of sedation and postoperative pain/discomfort were performed 15 minutes, 30 minutes, 1, 2, 3, 4, 5 and 6 hours after the end of the surgery when the dogs were discharged. The dogs were provided with additional carprofen for 2 days (2 mg/kg/12 hours peroraly). The dogs that did not receive carprofen before the surgery were given carprofen 4 mg/kg intramuscularly by a third person for ethical reasons at the time of discharge.
Each dog was monitored continuously and attended to if distressed during the postoperative observation period. The rescue protocol with methadone (Heptanon, Pliva) 0.3 mg/kg subcutaneously was provided in a case of significant pain i.e. when the pain score was above 6 on the multifactorial pain scale.
Postoperative sedation was assessed by: observing the dog's posture, its degree of mental alertness and its ability to stand and walk. In the discontinuous scoring system using simple numerical rating scale it was scored as follows: 0 fully alert and able to stand and walk, 1 alert and able to maintain sternal recumbency, not stable when trying to walk, 2 drowsy and able to maintain sternal recumbency but unable to stand, 3 fast asleep.
The degree of post-operative pain/discomfort was assessed with multifactor pain scale consisting of a number of simple descriptive scale values relating to the particular aspects of behaviour that may be associated with pain ( Table 1 ). The sum of numeric scores ranged from 0 to 9 as follows: 0 complete analgesia, with no overt signs of discomfort and no reaction to firm pressure, 1 -3 good analgesia, with no overt signs of discomfort but reaction to firm pressure, 4 -6 moderate analgesia, with some overt signs of discomfort which were made worse by firm pressure, 7 -9 poor or no analgesia, with obvious signs of persistent discomfort made worse by firm pressure. In addition to this scoring system, pulse rate, respiratory rate and rectal body temperature were measured at each assessment. 
Statistical analysis
The data were analysed by use of commercial software (SPSS 10.0 for Windows). Unless otherwise stated, all reported values are given as mean ±SD. Measurements of physiological parameters such as RR, TV, T, HR, pulse rate and MAP during and after the surgery were compared by using two-way ANOVA. The sedation and pain scores were compared by the Kruskal-Wallis non-parametric test at each time point. Student's paired t-test was used to assess the differences in the pulse rate, RR and T before and after medetomidine premedication. A value of P £ 0.05 was considered significant.
RESULTS
Pulse rate significantly decreased after medetomidine administration from 115.1±14.2 to 53.2±19.4 beats/min, and respiratory rate from 98.7±34.8 to 30.7±36.5 breaths/min in the carprofen group. In the placebo group, pulse rate significantly decreased after medetomidine administration from 115.7±7.5 to 51.0±14.1 beats/min, and respiratory rate from 101.4±31.8 to 20.1±4.0 breaths/min. Body temperature slightly increased after medetomidine administration in both treatment groups i.e. from 38.7±0.5 to 38.8±0. During anaesthesia, the heart rate was higher in the placebo group. The difference was significant only at phase 4 i.e. at first major painful stimulus (traction of left ovarian ligament) when the HR increased in both treatment groups (Fig 1) .
Mean arterial pressure was higher in the placebo group. The difference was significant at phases 1 to 3, after which MAP increased in both treatment groups (Fig 2) .
Respiratory rate was higher in the placebo group with the only significant difference at phase 8 (suturing the skin). An increase in RR was noted in both treatment groups at the two most painful stimuli (traction of left and right ovarian ligament) (Fig 3) .
Tidal volume of respiration was higher in the carprofen group except at phase 7 (suturing the abdominal wall). The difference between the treatment groups was not significant (Fig 4) .
Body temperature slightly decreased during anaesthesia in both treatment groups; however the temperature was within the physiological limits throughout the experiment. In the carprofen group, the temperature decreased from 38.3±0. at phase 4 when the first major painful stimulus occurred (pulling the left ovarian ligament) ( Table 2) . The sedation scores were zero before the surgery in all dogs and rose to high values immediately after the surgery. At 15 minutes after surgery, 6 dogs had a sedation score of 3, one dog had a sedation score of 2 and one had a sedation score of 1 in both treatment groups. At 30 minutes after surgery i.e. 15 minutes after atipamezole administration, only 3 dogs in the placebo group had a sedation score of 1. All the dogs from the carprofen group had a sedation score 0. No sedation was detected in any of the groups by 6 hours after the surgery. There was no significant difference in sedation scores between the groups at any time of assessment.
The post-operative pain scores were higher in the placebo group except at one hour after surgery. The highest pain scores in both treatment groups were observed 30 minutes after surgery after which they decreased and remained relatively low until the end of the observation period in both treatment groups. The difference between the groups was not significant at any time of assessment ( Fig  5) .
In addition to the pain scoring system, no significant difference between the treatment groups was observed in post-operative pulse and respiratory rate (Table 3) . Body temperature increased after surgery in both treatment groups, i.e. from 38.2±0.5 to 38.4±0. Laredo et al., 2004) . However, it is unclear whether pre-operative administration of carprofen decreases the anaesthetic requirements of injectable and volatile anaesthetics i.e. whether it has an anaesthetic sparing effect or not.
It has been suggested that pre-operative administration of carprofen reduces the amount of isoflurane, as reflected by MAC (minimal alveolar concentration), needed for anaesthesia in dogs (Ko et al., 2000) . These authors assumed that the data provide a strong indication that carprofen may in fact have an effect on the MAC of isoflurane in dogs, even though the differences between carprofen and control group were not significant in their study. They suspected that the inability to detect a significant decrease in MAC was the small sample size In the present study, dogs responded to painful intra-operative stimuli with increased heart rate, arterial blood pressure and respiratory rate, and with decreased tidal volume of respiration, which is in accordance with literature data (Hall et al., 2001) . Significantly lower heart rate and mean arterial blood pressure were observed in the carprofen group only in the early intra-operative period until major painful stimuli occurred (traction and severance of ovarian ligament). Respiratory rate was lower and tidal volume of respiration higher most of the time in dogs given carprofen; however the differences were not significant. Although most of the dogs from both groups required additional analgesia at the first major painful stimulus, authors speculate that carprofen provided some intra-operative analgesia during surgery.
Carprofen has been shown to be more effective when given before rather after surgery, by both mechanical threshold testing (Lascelles et al., 1997 , Lascelles et al., 1998 and behavioural measures (Lascelles et al., 1997 . For this reason it was administered pre-operatively in the present study. To avoid masking of carprofen post-operative effects with other anaesthetic drugs an anaesthetic protocol that provided minimal post-operative effects was selected deliberately. For ethical reasons, a rescue protocol with methadone was provided, but according to selected pain-scoring system there was no need to use it in any of the dogs. Validation of a pain assessment requires inclusion of animals, which received the anaesthetic but did not undergo any surgery, to determine the effects of anaesthesia in the absence of painful procedure (Flecknell 1994) . However, to include such a group was not possible owing to the clinical nature of the trial.
There was no significant difference between the dogs treated with carprofen or placebo in the present study in terms of respiratory and pulse rate after the surgery. Previous studies have failed to observe correlation between physiological measurements such as heart and respiratory rate (Holton et al., 1998) or arterial blood pressure and the severity of pain, which may also be the case in the present study.
Pain score was higher in the placebo group (except 1 hour after the end of the surgery) in the present study, although not significantly. Authors can only speculate that lower pain scores in carprofen treated dogs might be due to carprofen analgesic effect. The number of animals was too low to draw any firm conclusions. On the other hand, the pain scoring system was probably not sensitive enough in assessing the actual level of pain, since it is difficult to accept that none of the dogs from the placebo group required additional post-operative analgesia according to our pain assessment score.
Pain score decreased with time in both groups. T max (time to reach maximum plasma concentration) of 3 hours was reported for carprofen after subcutaneous pre-operative administration in dogs (Lascelles et al., 1998) . This is in accordance with analgesic activity of carprofen observed in the present study although carprofen was given intramuscularly. On the contrary, studies in horses Lees 1984, Lees and Higgins 1985) and dogs (Lascelles et al., 1998) suggested that plasma drug concentrations of different NSAID's are not a useful guide for their therapeutic activity at any given time.
Low postoperative pain score in both groups of dogs could have resulted from: (a) ketamine, which was used in subanaesthetic doses in both groups to improve analgesia during surgery, and has a potential for preventing hyperalgesia some 10 -12 hours post-administration (Slingsby and Waterman-Pearson 2000); (b) a possible pre-emptive effect of medetomidine in terms of decreasing the amount of noxious information generated at the periphery, or by blocking the entry of the noxious information into the spinal cord, thus decreasing any central changes or; (c) relatively small surgical wound of maximum 3 cm associated with minimal tissue damage.
Pain assessments made immediately after surgery may be difficult to interpret because of changes associated with recovery from anaesthesia, such as residual sedation or shivering ). Drug-induced sedation can mask the presence of pain by dampening the overt signs even though the pain may not be attenuated, and is therefore important to distinguish between sedation and analgesia. High sedation score before atipamezole administration in the present study was most probably due to medetomidine sedative effects, and as soon as medetomidine was antagonised, sedation score decreased in both groups of dogs. All dogs from carprofen group were fully alert and able to walk 30 minutes after the end of the surgery comparing to only 5 of 8 dogs in placebo group. The authors suspect that higher sedation score in early post-operative period in placebo group was due to the presence of pain, which was probably misinterpreted in terms of sedation, since most of medetomidine sedative and analgesic effects were already antagonised.
In conclusion, the results of the present study are conflicting regarding intraand post-operative analgesic efficacy of carprofen in medetomidinepremedicated dogs undergoing surgical procedures. The difference in antinociception between carprofen and placebo group was observed only until the first intense painful surgical stimulus occurred. The authors suspect that carprofen provides some additional intra-operative analgesia. As there was no difference in post-operative pain score it is possible that both groups were equally pain-free or painful. Based on known analgesic efficacy of carprofen under other conditions and the evidence for problems using the multifactorial pain scoring
